Tuesday, 2 January 2018

NEW PATENTS 2 ND JAN 2018

New patents,

Sr no
Patent number
name
company
INDICATION
REMARKS, WAIT FOR STR TO APPEAR
1
WO-2017223320

GALETERONE
UNIV OF MARYLAND

Prostate tumor

Galeterone.svg
2
WO-2017222819

IXAZOMIB
TEVA
Multiple myeloma
Ixazomib.svg
3
WO-2017221272

IDELALISIB
SUN
Chronic lymphocytic leukemia; Non-Hodgkin lymphoma
Idelalisib.svg






4
WO-2017221261
POMALIDOMIDE
NATCO
Multiple myeloma
Pomalidomide enantiomers.svg
5
WO-2017221214

LENVATINIB
SUN
Adenocarcinoma; Anaplastic thyroid cancer; Hepatocellular carcinoma; Medullary thyroid cancer; Neuroendocrine tumor; Renal cell carcinoma; Thyroid tumor
Lenvatinib skeletal.svg
6
WO-2017221213

ELUXADOLINE
SUN
Diarrhea predominant irritable bowel syndrome
Eluxadoline.svg
7
WO-2017221211

DAPAGLIFLOZIN
BIOCON
Diabetes mellitus
Haworth projection of dapagliflozin.svg
8
WO-2017221189

TENOFOVIR
LAURUS
Hepatitis B virus infection
Tenofovir alafenamide structure.svg
9
WO-2017221187

PRASUGREL
GEDEON
Acute coronary syndrome; Ischemic heart disease
Prasugrel racemic.svg
10
WO-2017221163

PANOBINOSTAT
ALEMBIC
Graft versus host disease; Multiple myeloma; Neuroendocrine tumor
Panobinostat.svg
11
WO-2017221144

ELAGOLIX
DR REDDYS
Endometriosis
Elagolix.svg
12
WO-2017220486

URSODEOXYCHOLIC ACID
PHARMAZELL
Cholelithiasis; Hepatitis; Liver disease; Primary biliary cirrhosis
Ursodeoxycholic acid acsv.svg
13
WO-2017220208

RALTEGRAVIR
PHARMATHEN

Raltegravir structure.svg
14
US-20170362175

APREMILAST
JOHNSON MATHEY
Behcets disease; Psoriasis; Psoriatic arthritis
Apremilast.svg
15
WO-2017223155
CENICRIVIROC
TOBIRA

Cenicriviroc.svg














No comments:

Post a Comment